Alterations of prostate biomarker expression and testosterone utilization in human LNCaP prostatic carcinoma cells by garlic-derived S-allylmercaptocysteine

Prostate

Volumn 45, Issue 4, 2000, Pages 304-314

  Pinto, John Thomas ^a   Qiao, Changhong ^a   Xing, Jie ^a   Suffoletto, Brian P ^a   Schubert, Kristin B ^a   Rivlin, Richard S ^a   Huryk, Robert F ^a   Bacich, Dean J ^a   Heston, Warren D W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Allylsulfides; Folate hydrolase; N acetyl aspartylglutamate; PSA; PSMA; Testosterone

Indexed keywords

ALLYL SULFIDE; BIOCHEMICAL MARKER; GAMMA GLUTAMYL HYDROLASE; MEMBRANE ANTIGEN; N ACETYLASPARTYLGLUTAMIC ACID; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CULTURE; CELL LYSATE; CELL PROLIFERATION; ENZYME ACTIVITY; EPITHELIUM CELL; GARLIC; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CARCINOMA; RADIOIMMUNOASSAY; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; CARBOXYPEPTIDASES; CELL DIVISION; CULTURE MEDIA; CYSTEINE; DRUG INTERACTIONS; GAMMA-GLUTAMYL HYDROLASE; GARLIC; GLUTAMATE CARBOXYPEPTIDASE II; GROWTH INHIBITORS; HUMANS; MALE; PLANTS, MEDICINAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SECRETORY RATE; TESTOSTERONE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0033669749     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0045(20001201)45:4<304::AID-PROS4>3.0.CO;2-9     Document Type: Article

References (50)

1. Therapeutic actions of garlic constituents
2. Allium vegetables and reduced risk of stomach cancer
3. A case-control study of gastric cancer and diet in Italy
4. A case-control study of diet and prostate cancer
5. Modulation of rat hepatic cytochrome P450 activity by garlic organosulfur compounds
6. Transcriptional activation of P-450 2B1/2 genes in rat liver by diallyl sulfone, a compound derived from garlic
7. P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature
8. Effect of diallyl sulfide on rat liver microsomal nitrosamine metabolism and other monooxygenase activities
9. Inhibition of cytochrome P-450 IIE1 by diallyi sulfide and its metabolites
10. Thioallyl compounds: Potent inhibitors of cell proliferation
11. Impact of organosulfur compounds in garlic on canine mammary tumor cells in culture
12. Growth inhibition and modulation of cell markers of melanoma by S-allyl cysteine
13. Antiproliferative effect of the garlic compound S-allyl cysteine on human neuroblastoma cells in vitro
14. Antitumor-promoting activity of garlic extracts
15. Novel anti-carcinogenic activity of an organosulfide from garlic: Inhibition of H-RAS oncogene transformed tumor growth in vivo by diallyl disulfide is associated with inhibition of p21(H-ras) processing
16. Effects of garlic thioallyl derivatives on growth, glutathione concentration, and polyamine formation of human prostate carcinoma cells in culture
17. LNCaP model of human prostatic carcinoma
18. Monoclonal antibodies to a new antigenic marker in epithelial cells and serum of prostatic cancer patients
19. National Cancer Institute roundtable on prostate cancer: Future research directions
20. Androgen-receptor gene structure and function in prostate cancer
21. Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors
22. Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP
23. Androgen up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line
24. The effect of finasteride on the prostate specific antigen: Review of available data
25. Finasteride: The first 5α-reductase inhibitor
26. Human prostate tumor growth in athymic mice: Inhibition by androgens and stimulation by finasteride
27. Expression of the prostate-specific membrane antigen
28. Upregulation of prostate specific membrane antigen after androgen deprivation therapy
29. Prostate-specific membrane antigen: A novel folate hydrolase in human prostatic carcinoma cells
30. Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase
31. Enzyme nomenclature recommendations 1992. Supplement 4 corrections and additions
32. Prostate specific membrane antigen: A unique folate hydrolase. A Review of recent findings
33. Human cytochrome P450 enzymes
34. Androgen receptor gene expression in human prostate carcinoma cell lines
35. Physiological control of prostatic growth: A preview
36. Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated α-linked acidic dipeptidase activity from rat brain
37. Measurement of steroid hydroxylation reactions by high-performance liquid chromatography as indicator of P450 identity and function
38. Formation of a novel topotecan metabolite in the hormone-independent human prostate carcinoma cell lines DU-145 and PC-3
39. The epidemiology of prostatic cancer. Geographical distribution and time-trends
40. Risk factors for prostate cancer
41. Diallyl disulfide suppresses the growth of human colon tumor cell xenografts in athymic nude mice
42. Garlic and other allium vegetables in cancer prevention
43. Differential effects of dietary diallyl sulfide and diallyl disulfide on rat intestinal and hepatic drug-metabolizing enzymes
44. Increased UDP-glucuronosyltransferase activity and decreased prostate specific antigen production by biochanin A in prostate cancer cells
45. Can nutrition explain the pattern of international epidemiology of hormone-dependent cancers?
46. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet
47. Effects of dietary fat and fiber on plasma and urine androgens and estrogens in men: A controlled feeding study
48. Prostate specific membrane antigen, a unique folate hydrolase: Potential target for prodrug therapy
49. The importance of steroid hormones in prostate cancer
50. The pathogenesis of benign prostatic hyperplasia